Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jan 31, 2014
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Sale
Common Stock
2014-01-30$5.57/sh−100,000$556,500→ 409,665 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.63 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.